Single subject design is a powerful research tool, particularly in clinical psychology, special education, and behavioral therapy. By using the individual as their own control, researchers can evaluate treatment effects with precision and immediacy. But this methodology is not without its complications. Critics have pointed to a range of structural, ethical, and practical limitations that can compromise the rigor and reach of single subject research. Understanding these disadvantages is not about dismissing the method – it’s about using it more responsibly and effectively.
Table of Contents
- The carry-over effect problem
- Order effects and sequence bias
- Irreversibility: when you can’t go back
- Ethical concerns with treatment withdrawal
- Baseline problems: the foundation that shifts
- Researcher bias in data collection and interpretation
- Practical limitations: time, resources, and scope
- The external validity gap
- Navigating limitations through better design choices
The carry-over effect problem
One of the most fundamental challenges in single subject design is the carry-over effect – when the influence of one treatment phase continues to bleed into the next. This is especially evident when the intervention involves learning a new skill or thinking pattern. Practice theories such as behavioral or cognitive-behavioral treatment are based on the idea that therapeutic effects will persist, which is exactly what makes withdrawal designs so complicated. If a participant genuinely internalizes a new strategy, they’ll keep using it even after the intervention is officially removed – making it nearly impossible to get a clean “return to baseline.”
This matters because many single subject designs, particularly ABAB reversal designs, depend on the assumption that removing an intervention will reverse the behavior change. When behavior is not reversible – such as when one’s objective is to teach a new skill the individual could not previously perform – returning to baseline conditions would not likely cause the individual to “unlearn” the behavior. The carry-over effect, then, doesn’t just complicate data interpretation; it can make entire design formats unsuitable for certain types of research questions.
Order effects and sequence bias
Order effects occur when the sequence in which treatments are presented – rather than the treatments themselves – influences the outcome. This is particularly problematic in alternating treatment designs, where researchers rapidly switch between multiple interventions to compare their effectiveness. The order of presentation can create practice effects, where improvement stems from simple familiarity with the experimental situation, or contrast effects, where one treatment looks better or worse simply because of what preceded it.
The ordering of the intervention or treatment affects what results emerge, and unlike group designs where counterbalancing can distribute these effects across participants, single subject designs must manage order effects within the same individual. There are no ideal solutions – only imperfect strategies like randomizing treatment order within sessions. This leaves findings potentially confounded by sequence rather than by the true effectiveness of an intervention.
Irreversibility: when you can’t go back
Closely tied to carry-over effects is the problem of irreversibility. Many single subject designs – particularly withdrawal or reversal designs – require that behavior return to baseline levels once an intervention is removed. But this assumes behavior is reversible. For many cognitive, educational, and skill-based interventions, this assumption simply does not hold.
In some cases, the behavior may come to be maintained by other contingencies not under the control of the experimenter, making a clean return to baseline impossible regardless of whether the intervention is withdrawn. When irreversibility is expected from the outset, researchers are forced to rely on alternative designs such as multiple baseline designs – which, while useful, introduce their own methodological constraints.
Ethical concerns with treatment withdrawal
Perhaps one of the most pressing real-world criticisms of single subject design is its ethical dimension. Many designs require the deliberate withdrawal of a treatment that appears to be working – and this creates significant moral tension, especially when the participant is a child, a clinical patient, or someone engaging in harmful behaviors.
Ethical concerns arise because some behaviors cannot be ethically reversed, particularly in high-risk situations. Consider a study evaluating a behavioral intervention for a child who engages in self-injury. If the intervention is working, withdrawing it – even briefly – means the child may harm themselves again during the return-to-baseline phase. Researchers are caught between methodological rigor and the ethical imperative to protect participants’ wellbeing.
This dilemma is not simply academic. Ethical considerations regarding the withdrawal of the intervention and the reversibility of the behavior need to be taken into account before the study begins – yet in practice, these decisions can be difficult to anticipate fully. The ABA design is particularly criticized here, as it ends with the participant in the baseline (no intervention) condition, which is problematic when the intervention was genuinely beneficial.
Baseline problems: the foundation that shifts
The entire logic of single subject design rests on the stability of the baseline – the pre-intervention behavior used to predict what would have happened without treatment. But baselines are not always stable. Behavior fluctuates naturally, and variable baselines – where scores shift widely without any clear pattern – make it genuinely difficult to detect whether an intervention had any real effect.
When repeated measurements are taken during the baseline phase, problems of maturation, instrumentation, statistical regression, and testing may be controlled, but only if enough data points are collected to reveal consistent patterns. The challenge is that there are no universally agreed-upon rules for how many data points constitute a “stable enough” baseline. In single-subject designs, decisions about when to alter phases are often made as data are collected, and conflicting ideas could emerge as to how a research experiment should be conducted. This opens the door to subjectivity at a stage that is supposed to be objective.
When a participant’s behavior is deteriorating during the baseline phase, researchers also face ethical pressure to begin the intervention early – before a stable baseline has been established. This forces a trade-off between methodological soundness and participant welfare that has no clean resolution.
Researcher bias in data collection and interpretation
Single subject research is especially vulnerable to researcher bias because the same individual often wears multiple hats – collecting data, deciding when to change phases, and interpreting the results. This concentration of roles creates multiple opportunities for unconscious bias to influence the outcome.
Decision bias affects when phase changes occur. A researcher invested in demonstrating treatment effectiveness may shift from baseline to intervention – or back again – at the most favorable moment. Interpretation bias compounds this problem during data analysis. The reliability and validity of visual inspection can be low, with reported inter-rater agreement among behavioral journal reviewers as low as .61 in some studies, indicating that two trained researchers looking at the same graph can reach significantly different conclusions.
As noted in discussions of research ethics more broadly, the influence of personal opinions and biases on scientific conclusions is a threat to the advancement of knowledge, and expertise does not render one immune to this temptation. Visual inspection – the primary method of analysis in single subject research – amplifies this risk, since it depends on the researcher’s judgment about whether the differences between phases are meaningful.
Practical limitations: time, resources, and scope
Beyond conceptual challenges, single subject design also presents significant practical limitations. The research is inherently time-intensive. Single subject research is time-consuming and generally takes several fortnights or months to complete, whereas much larger research designs can sometimes be carried out in only one session. Repeated observations across multiple phases demand consistent conditions over extended periods – and real-world participants rarely live in controlled, unchanging environments.
Maintaining a participant’s availability and cooperation over weeks or months is another logistical hurdle. Life events, illness, dropout, and shifting circumstances can disrupt data collection in ways that are far harder to manage in single subject designs than in group studies where individual attrition is absorbed by larger samples. These practical constraints can limit the types of research questions that single subject designs can feasibly address.
The external validity gap
Perhaps the most frequently cited limitation of single subject design is its restricted external validity – the degree to which findings can be generalized beyond the individual studied. Single subject designs are “weak when it comes to external validity,” and studies showing a particular treatment to be effective must rely on replication across individuals rather than groups if results are to be found worthy of generalization.
Group research is necessary to answer questions that cannot be addressed using the single-subject approach, including questions about independent variables that cannot be manipulated, such as number of siblings, extraversion, or culture. Because findings from a single participant (or a small handful of participants) reflect that individual’s unique context, history, and characteristics, extending those conclusions to broader populations requires extensive replication – across different participants, settings, researchers, and time points. This is not impossible, but it transforms what is often a single study into a full research program.
The generalizability problem is further complicated by the fact that external validity, when balanced against internal validity, is typically left with limited control in single subject designs. Researchers can partially address this by selecting participants who are representative of the broader population for which an intervention is intended, but this introduces new decisions about participant selection that add another layer of subjectivity.
Navigating limitations through better design choices
None of these disadvantages render single subject design invalid or unusable. No experimental design comes without limitation, and single-subject methods can complement group methodologies by addressing important points of internal validity and enabling the inductive process characteristic of quality early research. The key is awareness. Researchers who recognize these limitations can take proactive steps – using multiple baseline designs when reversibility is problematic, employing multiple observers to reduce interpretation bias, collecting more extensive baseline data to ensure stability, and being transparent in reporting about the study’s constraints.
Replication remains the most powerful tool for addressing external validity concerns. Each time a finding is replicated – across different individuals, settings, or researchers – confidence in the generalizability of results grows. Serial replications often enable detailed distillation of both common and uncommon relevant factors across individuals, making the approach particularly powerful for identifying generalizable processes that account for within-population diversity. This is how single subject research, despite its limitations, has contributed foundational knowledge to psychology – including the principles of Pavlovian and operant conditioning.
What do you think? When a treatment appears to be working but the research design requires its withdrawal, how should researchers weigh methodological integrity against participant welfare? And given that single subject findings are difficult to generalize, what level of replication do you think is needed before a finding should influence real-world clinical practice?
References
- https://en.wikipedia.org/wiki/Single-subject_design
- https://us.sagepub.com/sites/default/files/upm-binaries/25657_Chapter7.pdf
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3992321/
- https://behavioranalyststudy.com/single-subject-experimental-design/
- https://academy.pubs.asha.org/2011/03/issues-in-single-subject-research/
- https://onlineethics.org/cases/oec-subject-aids/bias-research-subject-aid
- https://egyankosh.ac.in/bitstream/123456789/23402/1/Unit-4.pdf
- https://researchbasics.education.uconn.edu/single-subject-research/
- https://opentext.wsu.edu/carriecuttler/chapter/10-3-the-single-subject-versus-group-debate/
- https://www.ncbi.nlm.nih.gov/pmc/articles/mid/NIHMS5086/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10634204/
Leave a Reply